Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Progress Software Q2 2026 Earnings Call - AI Data Context Drives Broad Portfolio Strength and Raised Guidance
Progress Software delivered a quarter of broad-based execution that quietly outpaced expectations across the board. Revenue hit $253 million, up 7% year-over-year, while adjusted free cash flow nearly...
- Revenue of $253 million rose 7% year-over-year, exceeding the high end of guidance, driven by broad-based strength across data platform, infrastructure management, and workflow automation products.
- Adjusted free cash flow nearly doubled to $79 million, up from $37 million in the prior year quarter, fueled by improved collections and a four-day reduction in days sales outstanding to 49 days.
- Earnings per share reached $1.62, significantly beating the high end of guidance, while operating margin held steady at 40% despite incremental investments in AI and sales capabilities.
- +7 more takeaways
Elite Pharmaceuticals FY2026 Earnings Call - Record Revenue Growth and Nasdaq Listing Consideration
Elite Pharmaceuticals delivered a record-breaking fiscal year 2026, with revenues surging 77% to $149 million and operating income more than tripling to $49 million, driven by the successful execution...
- Fiscal 2026 revenues reached $149 million, a 77% increase from $84 million in FY2025, marking the third consecutive year of record growth for the Elite label.
- Operating income surged 151% to $49 million, up from $20 million in FY2025, with profits more than quadrupling since the Elite label's inception in FY2024.
- Cash and cash equivalents nearly tripled to $29.8 million from $11.3 million, while working capital increased 106% to $95 million, reflecting a significantly strengthened balance sheet.
- +7 more takeaways
PetVivo Holdings FY 2026 Earnings Call - AI Platform Launch and Spryng Expansion
PetVivo Holdings reported mixed fiscal 2026 results. Revenue grew a modest 1% to $1.14 million, driven by its flagship Spryng device, but gross margins contracted sharply to 66.1% from 87.8% due to th...
- Revenue grew a modest 1% to $1.14 million in fiscal 2026, with $886,000 from distributor sales and $255,000 from direct clinic sales.
- Gross margins contracted significantly to 66.1% from 87.8% in the prior year, primarily due to the low-margin PrecisePRP product line.
- Net loss widened to $10.5 million ($0.38 per share) from $8.4 million ($0.41 per share), driven by an $1 million impairment on PrecisePRP and higher operating expenses.
- +13 more takeaways
Concentrix Q2 2026 Earnings Call - iX Suite Revenue Acceleration Drives Margin Expansion Amid Offshoring Headwinds
Concentrix delivered a pivotal second quarter in 2026, marked by a dramatic acceleration in its technology-led strategy. The iX Suite saw record contract signings, up 400% year-over-year, and the comp...
- iX Suite contract signings surged 400% year-over-year in Q2 2026, with nearly 100 deals closed, signaling strong demand for the company's technology-led solutions.
- Concentrix is on track to double iX Suite revenue to over $120 million in annual recurring revenue by the end of fiscal 2026, with 11% of total revenue now influenced by iX Suite deployments.
- Clients using the iX Suite are growing significantly faster than the consolidated average, delivering nearly 350 basis points of margin improvement and purchasing additional licenses within the first year.
- +7 more takeaways
AeroVironment Q4 FY2026 Earnings Call - Record Revenue and Aggressive Manufacturing Expansion
AeroVironment delivered record fourth-quarter and full-year fiscal 2026 results, driven by surging demand for its autonomous systems and counter-UAS platforms. Full-year revenue reached nearly $2 bill...
- Full-year fiscal 2026 revenue reached nearly $2 billion, with Q4 revenue of $642 million, representing 31% organic growth year-over-year.
- Full-year adjusted EBITDA was $286 million, exceeding the high end of guidance, with a 14% margin.
- Total bookings for the full year were $2.7 billion, indicating strong demand across the portfolio.
- +10 more takeaways
Apogee Enterprises FY2027 Q1 Earnings Call - Kalwall Acquisition Signals Shift to High-Margin, Specification-Driven Growth
Apogee Enterprises delivered a solid first quarter despite headwinds from rising input costs and soft demand in new construction. Revenue of $343 million and adjusted diluted EPS of $0.57 beat expecta...
- Revenue of $343 million and adjusted diluted EPS of $0.57 beat expectations, supported by pricing actions and cost savings from Fortify Phase 2.
- The company is acquiring Kalwall, a high-performance daylighting solutions provider, to diversify into specification-driven, higher-margin markets like education and healthcare.
- Kalwall is expected to generate approximately $85 million in revenue with a 15% EBITDA margin in the first year, with a long-term margin target of 20%.
- +7 more takeaways
Cineverse Q4 FY2026 Earnings Call - Acquisitions Drive Revenue Surge and Strategic Pivot to Ad-Tech
Cineverse reported a sharp revenue jump in Q4 FY2026, driven by partial contributions from its recent acquisitions of Giant Worldwide and IndiCue. The company is pivoting from a pure-play content stud...
- Q4 FY2026 consolidated revenue surged 67% year-over-year to $26 million, boosted by $11.6 million in partial-quarter contributions from the Giant Worldwide and IndiCue acquisitions.
- Cineverse returned to profitability with $1.1 million in net income, a significant improvement from the $1.1 million net loss in the prior year period, aided by a $4.3 million bargain purchase gain and $2.9 million in tax benefits.
- The company reaffirmed its FY2027 guidance of $115-$120 million in consolidated revenue and $10-$20 million in adjusted EBITDA, citing the full integration of its new acquisitions as a key driver.
- +7 more takeaways
Beyond Air (BYON) FY2026 Earnings Call - FDA Approval and Gen 2 Launch Drive Revenue Inflection
Beyond Air’s fiscal 2026 results mark a structural shift from a cash-burning development company to a scaling commercial operator. Revenue surged 107% to $7.7 million, driven by high customer retentio...
- Revenue surged 107% year-over-year to $7.7 million in fiscal 2026, driven by strong hospital adoption and high customer retention.
- Customer renewal rate hit approximately 90%, validating the clinical value and operational reliability of the current LungFit PH system.
- Gross profit swung from a $1.7 million loss to a $300,000 profit, representing a $2 million improvement and early signs of operating leverage.
- +9 more takeaways
OMS Energy Technologies Inc. FY2026 Earnings Call - Record Cash, Debt-Free Balance Sheet Amid Revenue Timing Headwinds
OMS Energy Technologies reported a full-year revenue decline to $155.9 million from $203.6 million in FY2025, driven by timing shifts in call-off orders from Saudi Aramco rather than lost demand. The ...
- Full-year revenue declined 23.5% to $155.9 million from $203.6 million in FY2025, primarily due to timing shifts in Saudi Aramco call-off orders rather than structural demand loss.
- Gross margin held firm at 30.3%, with sequential improvement in the second half as favorable revenue mix and cost discipline offset lower volumes.
- Record adjusted free cash flow of $52.5 million, up 39.4% year-over-year, driven by strong working capital management and inventory drawdown.
- +7 more takeaways
FedEx Freight Q4 2026 Earnings Call - Standalone Launch Delivers Strong Q4 Results and Clear Path to Margin Expansion
FedEx Freight successfully completed its spin from FedEx Corp. and launched as a standalone LTL carrier, reporting a solid Q4 2026 finish with $2.4B in revenue and a 15% adjusted operating margin. The...
- FedEx Freight officially launched as a standalone publicly traded company (FDXF) on June 1, 2026, marking the completion of its spin from FedEx Corp.
- Q4 2026 revenue reached $2.4 billion, up 5% year-over-year, driven by higher fuel surcharges and increased weight per shipment, partially offset by softer volumes.
- Adjusted operating income was $363 million, representing a 15% adjusted operating margin, despite ~$80 million in separation-related costs and a $33 million gain lapping from 2025.
- +7 more takeaways